A “ Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Martinis Massimo De; Sirufo Maria Maddalena; Ginaldi Lia

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2019 | Volume:21 | Issue:1 Page(s): 0-0

Download Full-Text

View:

319

Download:

177

Cites:

Information Journal Paper

Title

A “ Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report

Author(s)

Martinis Massimo De | Sirufo Maria Maddalena | Ginaldi Lia | Issue Writer Certificate

Keywords

Allergy

Anaphylaxis

Antihistamines

Anti-IgE Antibody

Cold

Immunology

Leukotriene Antagonist

Omalizumab

Oral Steroids

Physical Urticaria

Urticaria

Abstract

Introduction: One of the most common forms of Urticaria/fa?page=1&sort=1&ftyp=all&fgrp=all&fyrs=all" target="_blank">Physical Urticaria is the Cold Urticaria. It can be a medical emergency, since it can induce Anaphylaxis and edema of the glottis, and in any case, it is a condition that reduces the quality of life of the affected subjects forced to significantly limit their normal activities. Moreover, since the symptoms are triggered by exposure to Cold, which is difficult (if not impossible) to avoid in everyday life, a safe and effective therapy appears to be essential. Unfortunately, traditional therapies often cannot provide adequate and safe answers. Case Presentation: The current study reported the case of a 52-year-old female patient manifesting the first symptoms after going to the stadium to watch football games while sitting in the stands. On such occasions, her buttocks would begin to itch, and started swelling and reddening. These manifestations then occurred on other occasions of exposure to the Cold, and in other body areas. The patient visited the outpatient clinic of Allergy and Clinical Immunology Unit, Teramo General Hospital (Teramo, Italy), and was treated with sedating and non-sedating H1-blocking Antihistamines (Rupatadine, Cetirizine), a Leukotriene Antagonist, and Oral Steroids with no success; therefore, it was decided to treat her with Omalizumab, an Anti-IgE Antibody. Conclusions: The satisfactory response to Omalizumab in the patient, after the failure of previous standard therapeutic strategies, confirmed the effectiveness of this molecule to treat Cold Urticaria, which despite what reported in several studies, is not yet recognized and authorized by the competent health authorities in the treatment of this condition.

Cites

No record.

References

Cite

APA: Copy

Martinis, Massimo De, Sirufo, Maria Maddalena, & Ginaldi, Lia. (2019). A “ Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 21(1), 0-0. SID. https://sid.ir/paper/293844/en

Vancouver: Copy

Martinis Massimo De, Sirufo Maria Maddalena, Ginaldi Lia. A “ Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2019;21(1):0-0. Available from: https://sid.ir/paper/293844/en

IEEE: Copy

Massimo De Martinis, Maria Maddalena Sirufo, and Lia Ginaldi, “A “ Stadium” Urticaria, Cold Urticaria Is Still a Mostly Unknown Disease, with a Wide Spectrum of Severity Degrees and Few Therapeutic Certainties: Is Omalizumab One of These? Reflections from a Clinical Case Report,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 21, no. 1, pp. 0–0, 2019, [Online]. Available: https://sid.ir/paper/293844/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops